Is Placebo Still Ethical in Trials of Incretin Therapies?
Circulation · 07.04.2026 · 153 (14) · 1005-1008
DOI: 10.1161/circulationaha.125.077277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 07.04.2026. Verfasst von Brendon L Neuen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia (B.L.N.). Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia (B.L.N.).
- Department of Renal Medicine, Royal North Shore Hospital, Sydney, NSW, Australia (B.L.N.).
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.W.O., M.V.).
ORCID-Profile: Brendon L Neuen, John W Ostrominski, Muthiah Vaduganathan
Zitieren
APA
Neuen, B. L., Ostrominski, J. W., & Vaduganathan, M. (2026). Is Placebo Still Ethical in Trials of Incretin Therapies?. Circulation, 153(14), 1005-1008. https://doi.org/10.1161/circulationaha.125.077277
Vancouver
Neuen BL, Ostrominski JW, Vaduganathan M. Is Placebo Still Ethical in Trials of Incretin Therapies?. Circulation. 2026;153(14):1005-1008. doi:10.1161/circulationaha.125.077277
BibTeX
@article{Neuen2026,
author = {Neuen, Brendon L and Ostrominski, John W and Vaduganathan, Muthiah},
title = {Is Placebo Still Ethical in Trials of Incretin Therapies?},
journal = {Circulation},
year = {2026},
volume = {153},
number = {14},
pages = {1005--1008},
doi = {10.1161/circulationaha.125.077277}
}
EUVIMED